Buy PhaseRx Stock | PZRX Stock Price & Latest News | Public
PZRX

PhaseRx

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About PZRX

    PhaseRx, Inc. operates as a biopharmaceutical company that develops a portfolio of mRNA products to correct inherited, life-threatening liver diseases in children. Its product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency; argini...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$32,7k
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.01
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app